← back to search

Eliseo Güallar

McMaster University · CA
Area of research
Health, Toxicology and Mutagenesis · Epidemiology
Research interest
Chronic lymphocytic leukemia (CLL) can arise from lymphoid clonal hematopoiesis of indeterminate potential (L-CHIP), but many individuals who develop CLL lack detectable L-CHIP prior to diagnosis. To identify additional predictors of CLL risk, we analyze mitochondrial heteroplasmy in 419,154 individuals from the UK Biobank (UKB). Heteroplasmy is associated with a 1.5-fold increased risk of developing CLL, and this risk rises to 4-fold when accounting for deleterious heteroplasmic variants. These findings are confirmed in an independent cohort, the All of Us Research Program (AoU). Notably, the associations remain significant even in the absence of L-CHIP, highlighting heteroplasmy's potential utility as an independent biomarker.
h-index
118
citations
50,771
works
834
NIH funding
primary concept
email

Recent publications

Reporting guideline for Chatbot Health Advice studies: the CHART statement
BMC Medicine 2025cited by 7position: middledoi
Deleterious mitochondrial heteroplasmies exhibit increased longitudinal change in variant allele fraction
iScience 2025cited by 7position: selecteddoi
Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)
Circulation 2024cited by 32position: middledoi
Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity
Annals of Internal Medicine 2024cited by 17position: middledoi
A Metabolomics Approach to Identify Metabolites Associated With Mortality in Patients Receiving Maintenance Hemodialysis
Kidney International Reports 2024cited by 6position: middledoi
Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality
Nature Communications 2023cited by 38position: middledoi
Multivariate longitudinal data for survival analysis of cardiovascular event prediction in young adults: insights from a comparative explainable study
BMC Medical Research Methodology 2023cited by 17position: middledoi
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
Alimentary Pharmacology & Therapeutics 2022cited by 28position: middledoi
A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies
JAMA 2021cited by 501position: middledoi
Thinking outside the nucleus: Mitochondrial DNA copy number in health and disease
Mitochondrion 2020cited by 356position: middledoi
Evaluation of mitochondrial DNA copy number estimation techniques
PLoS ONE 2020cited by 155position: middledoi
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
Thorax 2020cited by 133position: middledoi
Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs
Genome Medicine 2020cited by 120position: middledoi
Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study
The Journal of Clinical Endocrinology & Metabolism 2020cited by 67position: middledoi
Mitochondrial DNA copy number and incident atrial fibrillation
BMC Medicine 2020cited by 39position: middledoi
Associations between <i>Helicobacter pylori</i> with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala
Helicobacter 2020cited by 32position: middledoi
Coffee and Tea Consumption in the Early Adult Lifespan and Left Ventricular Function in Middle Age: The CARDIA Study
ESC Heart Failure 2020cited by 16position: middledoi
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
Circulation 2019cited by 326position: middledoi
Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes
Annals of Internal Medicine 2019cited by 218position: middledoi
Racial Differences in Sudden Cardiac Death
Circulation 2019cited by 155position: lastdoi
Resting Heart Rate, Short-Term Heart Rate Variability and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis (MESA))
The American Journal of Cardiology 2019cited by 52position: middledoi
Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA
Journal of the American Heart Association 2019cited by 22position: middledoi
Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
Journal of the American College of Cardiology 2018cited by 420position: middledoi
Adiposity and Incident Heart Failure and its Subtypes
JACC Heart Failure 2018cited by 192position: middledoi
Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial
Free Radical Biology and Medicine 2018cited by 186position: middledoi
Incidence of Diabetes After Cancer Development
JAMA Oncology 2018cited by 157position: middledoi
A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease
International Journal of Epidemiology 2018cited by 110position: middledoi
Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease
Circulation Cardiovascular Quality and Outcomes 2018cited by 64position: middledoi
Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study
International Journal of Cardiology 2018cited by 57position: middledoi
Relation of Elevated Resting Heart Rate in Mid-Life to Cognitive Decline Over 20 Years (from the Atherosclerosis Risk in Communities [ARIC] Study)
The American Journal of Cardiology 2018cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Di Zhao · Johns Hopkins University21 papers (2014–2024)Juhee Cho · Daegu University15 papers (2012–2020)Ana Navas‐Acién · Columbia University15 papers (2012–2018)Erin D. Michos · Vanderbilt University Medical Center12 papers (2016–2020)Yiyi Zhang · Shanghai University of Traditional Chinese Medicine11 papers (2014–2019)Mariana Lazo · Drexel University10 papers (2013–2022)Álvaro Alonso · UMass Memorial Health Care9 papers (2016–2020)Kevin A. Francesconi · Nawi Graz8 papers (2012–2017)Walter Goessler · University of Graz8 papers (2012–2017)João A.C. Lima · University of Birmingham8 papers (2014–2023)Jason G. Umans · Georgetown University8 papers (2012–2017)Wendy S. Post · Bloomberg (United States)7 papers (2014–2020)Yoosoo Chang · Zero to Three7 papers (2014–2017)Barbara V. Howard · MedStar Health6 papers (2012–2017)María Téllez-Plaza · Georgetown University6 papers (2012–2014)Seungho Ryu · Aarhus University Hospital6 papers (2014–2017)Rebecca F. Gottesman · National Institute of Neurological Disorders and Stroke6 papers (2016–2024)Ye Qiao · University of Maryland, Baltimore6 papers (2016–2024)Bruce A. Wasserman · University of Maryland, Baltimore6 papers (2016–2024)Li Liu · University of Hong Kong5 papers (2016–2017)